For Americans taking T via tesosterone gel, there is an active recall due to carcinogen contaminates in the gel

Strides Pharma has recalled over 400,000 cartons of its Testosterone Gel 1% across the U.S. and Canada due to trace amounts of benzene, a known carcinogen. Although no injuries have been reported, transgender patients who use the gel are urged to review lot numbers and speak with providers about safe alternatives. This recall affects both 2.5-gram and 5-gram unit-dose packets distributed since 2023.